alexa Psoriasis|omicsgroup|Journal Of Aging Science

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Psoriasis

Journal of Aging Science is one of the best journals in in the field of Aging. All the contents published in the journal are very interesting and new in field of Aging. The aim of the journal is to provide all the latest information of the associated fields. It mainly deals with aging, reproductive aging, aging skin, biomarkers of aging, cognitive-aging, dementia, frailty, healthy-aging, geriatrics. Psoriasis is a chronic immune-mediated disease affecting the skin, nails and joints. In recent years it can be effectively treated with biological therapy. In Slovakia, 4 biologicals are approved for the treatment of psoriasis: infliximab, adalimumab, etanercept, and ustekinumab. Andrea Kovacikova Curkova, Management of Infliximab Treated Patients with Psoriasis Based On Infliximab Plasma Levels and Antibodies to Infliximab. OMICS Group is among the leading open access publishers with around 700+ peer-reviewed journals with several best quality peer-reviewed articles. It has more than 50,000+ editorial board members in its Editorial Board and many expert reviewers to carry rigorous peer-review process. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences across the globe. OMICS Group is having support of more than 1000+ Scientific associations, 50,000+ editorial board members and 15 million readers.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top